Deal expands global footprint of Anytime Fitness franchise fitness clubs and reflects its ambitions across Middle East; aligns with Saudi Vision: 2030 programs for health, wellbeing of all people across KSA; first club to open in Riyadh by spring 2026 Purpose Brands LLC is pleased to announce that Anytime Fitness, the world's largest fitness club […]

As an Oracle partner, I-care will leverage Oracle technologies to drive customer success I-care, a global leader in predictive maintenance, todayannounced that it has joined Oracle's enhanced partner program. For more than 40 years, Oracle has been working closely with partners to help drive joint customer success and business momentum. By joining OPN, I-care has

Wayfair Inc. (NYSE: W), the destination for all things home, today announced it will open its newest namesake retail location in Columbus, Ohio – one of the Midwest's fastest-growing metros – in late 2026. At approximately 70,000 square feet, or about half the size of previously announced Wayfair stores, the Columbus location will serve as

TransAlta Reports Third Quarter 2025 Results GlobeNewswire November 06, 2025 CALGARY, Alberta, Nov. 06, 2025 (GLOBE NEWSWIRE) — TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) today reported its financial results for the third quarter ended Sept. 30, 2025. “Our business delivered solid operational performance during the third quarter, demonstrating the Company's resilience

First Atlantic Nickel to Attend North American Stainless & Special Alloys Conference 2025, Highlighting Pipestone XL Nickel Alloy Project's Smelter-Free Processing and Chromium Byproduct Potential for North America's Critical Alloys Supply Chain GlobeNewswire November 06, 2025 NASHVILLE, Tenn., Nov. 06, 2025 (GLOBE NEWSWIRE) — First Atlantic Nickel Corp. (“First Atlantic or the “Company”) (TSXV: FAN)

Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates GlobeNewswire November 06, 2025 PrisMN Phase 2 trial of budoprutug in Primary Membranous Nephropathy (pMN) initiated Phase 1 trial of budoprutug subcutaneous formulation initiated, with initial data expected in H1 2026 Clinical trials of budoprutug in Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus

Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights GlobeNewswire November 06, 2025 PEMGARDA(R) (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth quarter-over-quarter October 2025 ending cash and cash equivalents of over $100 million; ended Q3 2025 with $85.0 million in cash and

TeamViewer, a global leader in digital workplace solutions, today announced a significant milestone in its journey to full FedRAMP authorization for the TeamViewer DEX platform (formerly 1E Platform). The company has successfully completed the build-out and compliance validation of its test environment, an important quality gate for the authorization of the live system. Mei Dent,

Agentic marketing platform launches in a wide-scale pilot in Nigeria with the intent to expand across the region MarkeTeam.ai and NorthBrix today announced a strategic collaboration to launch CyBrixTeam AI, a market-customized agentic marketing platform powered by MarkeTeam.ai's autonomous marketing technology. Under this agreement, NorthBrix will operate CyBrixTeam AI, launching a wide-span pilot in Nigeria

— Award recognizesSkylineDx's commitment to developing quality diagnostics that support clinicians and patients in optimizing personalized treatment plans — Annual Biotech Breakthrough Award Program recognizes inventions in life sciences and biotechnology around the world SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, and inflammatory and infectious diseases,